Chairman, Fortis Escorts Heart Institute & Lead Interventional Cardiologist
ID: DMC-08421
Delhi Medical Council (DMC) & National Medical Commission (NMC)
Dr. Ashok Seth is the Chairman of Fortis Escorts Heart Institute, Okhla, New Delhi, and one of the world's foremost interventional cardiologists. He has pioneered cutting-edge techniques in coronary angioplasty, TAVR/TAVI, and directional atherectomy with over 35 years of clinical practice.
Interventional Cardiology, Complex Angioplasty, TAVR/TAVI, Structural Heart Disease
35+ Years Interventional Cardiology
Chairman, Fortis Escorts Heart Institute, Okhla Road, New Delhi
“Angiographic Restenosis Dynamics and Long-Term Clinical Outcomes in Complex Coronary Interventions and Bioabsorbable Scaffolds”
Institution: Jawaharlal Nehru Medical College, AMU & Royal College of Physicians (UK)
Pioneering clinical cardiology dissertation analyzing plaque modification via directional coronary atherectomy, second-generation drug-eluting stents, and bioresorbable coronary scaffold biocompatibility in multivessel disease.
Dr. Seth reports no commercial affiliations or pharmaceutical sponsorships. Reviews strictly follow ACC/AHA and Cardiological Society of India (CSI) consensus.
Verified for medical accuracy, safety guidelines, and clinical evidence.
Heart HealthHypertension (BP ≥ 130/80 mmHg) is the leading modifiable risk factor for stroke, myocardial infarction, and chronic kidney disease. Learn the exact physiological mechanisms of non-pharmacological blood pressure reduction, including the dietary DASH protocol, sodium-potassium balance, isometric exercise, and autonomic stress modulation.
Heart HealthCoronary Artery Disease (CAD) is the leading cause of mortality worldwide, resulting from atherosclerotic plaque accumulation within the epicardial coronary vessels. Explore modern diagnostic algorithms (Coronary Artery Calcium scoring, CT Coronary Angiography), medical management (high-intensity statins, beta-blockers, ACE inhibitors), and revascularization indications.
Heart HealthAtrial Fibrillation (AFib) is the most common sustained cardiac arrhythmia, characterized by chaotic, disorganized electrical impulses firing in the atria at 300–600 bpm. Explore clinical stroke risk stratification using the CHA2DS2-VASc score, modern Direct Oral Anticoagulants (DOACs), rate vs. rhythm control strategies, and catheter pulmonary vein isolation.
Heart HealthAtherogenic dyslipidemia is a primary modifiable risk factor for atherosclerotic cardiovascular disease. Explore modern lipid science beyond basic total cholesterol—including Apolipoprotein B (ApoB), Non-HDL cholesterol, Lipoprotein(a), evidence-based statin dosing algorithms, and modern non-statin therapies (Ezetimibe, PCSK9 inhibitors).
Heart HealthHeart failure with preserved ejection fraction (HFpEF) occurs when the left ventricle becomes thick or stiff, preventing normal diastolic filling despite normal pumping capacity. Understand diagnostic markers like NT-proBNP, echocardiogram E/e' ratios, and evidence-based treatments including SGLT2 inhibitors and blood pressure control.
Heart HealthPeripheral artery disease (PAD) is caused by atherosclerotic narrowing in the lower extremity arteries, leading to exertional leg cramping (claudication), cold extremities, and slow-healing sores. Review diagnostic ABI thresholds, antiplatelet therapy, and supervised walking protocols.
Heart HealthHeart palpitations—the sensation of skipped beats, fluttering, or pounding in the chest—are most commonly caused by benign ectopic beats like PVCs and PACs. Learn how autonomic balance, electrolytes, and stimulants trigger extra beats, diagnostic monitoring methods, and warning signs requiring prompt medical evaluation.
